Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PULSO Trial: PLDR vs Standard CRT for Esophageal Cancer
NCT06906887Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2025
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Medical College of Wisconsin. Primary endpoints: New prescription for narcotics, Increasing existing narcotics and 1 more. Started Jun 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06906887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06906887.